Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.

Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.
复制标题

DOI:
10.1016/j.cmet.2012.03.019
复制
发表时间:
2012-05-02
期刊:
影响因子:
29
通讯作者:
Cleveland DW
Cleveland DW
中科院分区:
生物学1区
文献类型:
--
作者:
Da Cruz S;Parone PA;Lopes VS;Lillo C;McAlonis-Downes M;Lee SK;Vetto AP;Petrosyan S;Marsala M;Murphy AN;Williams DS;Spiegelman BM;Cleveland DW

文献摘要

参考文献

被引文献

相似文献

转录辅激活因子PGC-1α对肌肉产生多种作用,包括增加线粒体质量和活性。肌萎缩侧索硬化症(Amyotrophic lateral sclerosis,ALS)是一种进行性、致死性、成人发病的神经退行性疾病,其特征在于运动神经元的选择性丧失和骨骼肌变性。早期事件被认为是去神经诱导的肌肉萎缩,伴随着肌肉内线粒体活性和形态的改变。我们现在报告说,在ALS引起的SOD 1突变体导致致命性瘫痪的小鼠肌肉中,PGC-1α水平的升高会在整个疾病过程中升高PGC-1α依赖性途径。线粒体生物发生和活性在终末期疾病中得以维持,伴随着肌肉功能的保留、延迟的肌肉萎缩和即使在晚期疾病阶段也显著改善的肌肉耐力。然而,生存期并未延长。因此,肌肉不是突变SOD 1介导的毒性的主要靶点,但增加肌肉中PGC-1α活性的药物代表了在ALS进展期间维持肌肉功能的有吸引力的疗法。
The transcriptional coactivator PGC-1α induces multiple effects on muscle, including increased mitochondrial mass and activity. Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, adult-onset neurodegenerative disorder characterized by selective loss of motor neurons and skeletal muscle degeneration. An early event is thought to be denervation-induced muscle atrophy accompanied by alterations in mitochondrial activity and morphology within muscle. We now report that elevation of PGC-1α levels in muscles of mice that develop fatal paralysis from an ALS-causing SOD1 mutant elevates PGC-1α-dependent pathways throughout disease course. Mitochondrial biogenesis and activity are maintained through end-stage disease, accompanied by retention of muscle function, delayed muscle atrophy, and significantly improved muscle endurance even at late disease stages. However, survival was not extended. Therefore, muscle is not a primary target of mutant SOD1-mediated toxicity, but drugs increasing PGC-1α activity in muscle represent an attractive therapy for maintaining muscle function during progression of ALS.
DOI: 10.1016/j.neuron.2010.07.019
发表时间: 2010-08-26
期刊: NEURON
影响因子: 16.2
作者:
Israelson, Adrian;Arbel, Nir;Da Cruz, Sandrine;Ilieva, Hristelina;Yamanaka, Koji;Shoshan-Barmatz, Varda;Cleveland, Don W.
通讯作者: Cleveland, Don W.
DOI: 10.1371/journal.pone.0016870
发表时间: 2011-02-09
期刊: PloS one
影响因子: 3.7
作者:
Vandevenne P;Lebrun M;El Mjiyad N;Ote I;Di Valentin E;Habraken Y;Dortu E;Piette J;Sadzot-Delvaux C
通讯作者: Sadzot-Delvaux C
DOI: 10.1016/j.nbd.2006.05.009
发表时间: 2006-09-01
影响因子: 6.1
作者:
Holzbaur, Erika L. F.;Howland, David S.;Walsh, Frank S.
通讯作者: Walsh, Frank S.
DOI: 10.1093/hmg/ddq202
发表时间: 2010-08-01
影响因子: 3.5
作者:
Pedrini S;Sau D;Guareschi S;Bogush M;Brown RH Jr;Naniche N;Kia A;Trotti D;Pasinelli P
通讯作者: Pasinelli P
DOI: 10.1016/j.mad.2010.05.003
发表时间: 2010-07
影响因子: 5.3
作者:
Kawamata, Hibiki;Manfredi, Giovanni
通讯作者: Manfredi, Giovanni